Shopping Cart
Remove All
Your shopping cart is currently empty
LY2452473 (OPK 88004) is an orally available and selective androgen receptor modulator with potential anticancer activity for the study of prostate cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $30 | In Stock | In Stock | |
| 5 mg | $65 | In Stock | In Stock | |
| 10 mg | $93 | In Stock | In Stock | |
| 25 mg | $143 | In Stock | In Stock | |
| 50 mg | $188 | In Stock | In Stock | |
| 100 mg | $281 | In Stock | In Stock | |
| 200 mg | $429 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $70 | In Stock | In Stock |
| Description | LY2452473 (OPK 88004) is an orally available and selective androgen receptor modulator with potential anticancer activity for the study of prostate cancer. |
| In vivo | METHODS: The disposition and metabolism of LY2452473 in humans was characterized following a single oral dose of 15 mg (100 μCi) of [¹⁴C]LY2452473 in six healthy male subjects. RESULTS: LY2452473 was rapidly absorbed (time to maximum plasma concentrations of LY2452473 and total radioactivity was 2-3 hours) and slowly eliminated (plasma terminal half-life of 27 hours, duration of LY2452473 and total radioactivity of 51 hours). [1] |
| Synonyms | OPK-88004, OPK 88004, LY-2452473, LY 2452473 |
| Molecular Weight | 374.44 |
| Formula | C22H22N4O2 |
| Cas No. | 1029692-15-6 |
| Smiles | C(N1C2=C(C=3C1=CC=C(C#N)C3)C[C@H](NC(OC(C)C)=O)C2)C4=CC=CC=N4 |
| Relative Density. | 1.28 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (160.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.